Although dehydroepiandrosterone (DHEA) has long been considered as a precursor for steroid hormones, it has also been shown to have regulatory effects in immune homeostasis. We have examined the effect of high DHEA doses on T cell proliferation, differentiation, and cytokine secretion patterns following stimulation with mitogens and soluble antigens. DHEA profoundly inhibited T cell receptor-mediated T cell proliferation in the upstream of IL-2R signaling. Addition of DHEA to KLH-primed splenocytes stimulated Th2 response, indicated by an increase of IL-4 or a decrease of IFN-γ production in the cultures. Further studies showed that DHEA enhanced IL-4, but inhibited IL-12-mediated T cell proliferation and IL-12 production in antigen-presenting cells (APCs). Our data demonstrated that supraphysiologic levels of DHEA favored Th2 immune responses in vitro by inhibition of IL-12 production from APCs and/or stimulation of Th2 proliferation during the interactions of T cells with APCs.
BaulieuEE, EmiliozziR, LebeauMC, CorpechotC, RobelP.Studies of the secretion and the metabolism of steroid conjugates: synthesis, analysis, and use of doubly labeled compounds. Adv Tracer Methodol3:285–299, 1966.
2.
BaulieuEE, RobelP.Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) a neuroactive neurosteroids. Proc Natl Acad Sci U S A95:4089–4091, 1998.
3.
WeileRV, LiebermanS.The metabolism of dehydroisoandrosterone. In: PincusG, VollmerE, Eds. Biological Activities of Steroids in Relation to Cancer. New York: Academic Press, pp93–110, 1960.
4.
LabrieF, BelangerA, SimardJ, Luu-TheV, LabrieC.DHEA and peripheral androgen and estrogen formation: intracrinology. In: BellinoFL, DaynesRA, HornsbyPJ, LavrinDH, NestleJE, Eds. Dehydroepiandrosterone (DHEA) and Aging. New York: New York Academy of Science, Vol 774:pp16–28, 1995.
5.
LongcopeC.Metabolism of dehydroepiandrosterone. In: BellinoFL, DaynesRA, HornsbyPJ, LavrinDH, NestleJE, Eds. Dehydroepiandrosterone (DHEA) and Aging. New York: New York Academy of Science, Vol 774:pp143–148, 1995.
6.
LongcopeC.Andrenal and gonadal androgen secretion in normal females. Clin Endocrinol Metab15:213–228, 1986.
7.
OrentreichN, BrindJL, VogelmanJH, AndresR, BaldwinH.Long-term longitudinal measurement of plasma dehydroepiandrosterone sulfate in normal men. J Clin Endocrinol Metab75:1002–1004, 1992.
8.
MoralesAJ, NolanJJ, NelsonJC, YenSSC. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab78:1360–1367, 1994.
9.
MilewichL, CatalinaF, BennettM.Pleotropic effects of dietary DHEA. In: BellinoFL, DaynesRA, HornsbyPJ, LavrinDH, NestlerJE, Eds. Dehydroepiandrosterone (DHEA) and Aging. New York: New York Academy of Science, Vol 774:pp149–170, 1995.
10.
MajewskaMD. Neuronal actions of dehydroepiandrosterone: possible roles in brain development, aging, memory, and affect. In: BellinoFL, DaynesRA, HornsbyPJ, LavrinDH, NestleJE, Eds. Dehydroepiandrosterone (DHEA) and Aging. New York: New York Academy of Science, Vol 774:pp47–56, 1995.
11.
VermeulenA.Dehydroepiandrosterone sulfate and aging. In: BellinoFL, DaynesRA, HornsbyPJ, LavrinDH, NestlerJE, Eds. Dehydroepiandrosterone (DHEA) and Aging. New York: New York Academy of Science, Vol 774:pp121–127, 1995.
12.
BerrC, LafontS, DebuireB, DartiguesJ-F, BaulieuEE. Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: a French community-based study. Proc Natl Acad SciU S A93:13410–13415, 1996.
13.
AraneoBA, WoodMLII, DaynesRA. Reveral of the immunosenescent phenotype by dehydroepiandrosterone: hormone treatment provides an adjuvant effect on the immunization of aged mice with recombinant hepatitis B surface antigen. J Infect Dis167:830–840, 1993.
14.
JiangS, LeeJ, ZhangZ, InserraP, SolkoffD, WatsonRR. Dehydroepiandrosterone synergizes with antioxidant supplements for immune restoration in old as well as retrovirus-infected mice. J Nutr Biochem9:362–369, 1998.
15.
DaynesRA, AraneoBA, ErshlerWB, MaloneyC, LiGZ, RyuSY. Altered regulation of IL-6 production with normal aging: possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative. J Immunol150:5219–5230, 1993.
16.
InserraP, ZhangZ, ArdestaniSK, Araghi-NiknamM, LiangB, JiangS, ShawD, MolitorM, ElliottK, WatsonRR. Modulation of cytokine production by dehydroepiandrosterone (DHEA) plus melatonin (MLT) supplementation of old mice. Proc Soc Exp Biol Med218:76–82, 1998.
17.
ZhangZ, Araghi-NiknamM, LiangB, InserraP, ArdestaniSK, JiangS, ChowS, WatsonRR. Prevention of immune dysfunction and vitamin E loss by dehydroepiandrosterone and melatonin supplementation during murine retrovirus infection. Immunology96:291–297, 1999.
18.
Hernandez-PandoR, StreberMDLL, OrozcoH, ArriagaK, PavonL, Al-NakhliSA, RookGA. Effects of androstenediol and dehydroepiandrosterone on the course and cytokine profile of tuberculosis in BALB/c mice. Immunology95:234–241, 1998.
19.
CarrDJ. Increased levels of IFN-γ in the trigeminal ganglion correlate with protection against HSV-1-induced encephalitis following subcutaneous administration with androstenediol. J Neuroimmunol89:160–167, 1998.
20.
Araghi-NiknamM, ZhangZ, JiangS, CallO, EskelsoCD, WatsonRR. Cytokine dysregulation and increased oxidation is prevented by dehydroepiandrosterone in mice infected with murine leukemia retrovirus. Proc Soc Exp Biol Med216:386–391, 1997.
21.
BenND, PadgettDA, LoriaRM. Androstenediol and dehydroepiandrosterone protect mice against lethal bacterial infections and lipopolysaccharide toxicity. J Med Microbiol48:425–431, 1999.
22.
FeldmanHA, JohannesCB, McInlayJB, LongcopeC.Low dehydroepiandrosterone sulfate and heart disease in middle-aged men: cross-sectional results from the Massachusetts male aging study. Ann Epidemiol8:217–228, 1998.
23.
JanssonJH, NilssonTK, JohnsonO.von Willebrand factor, tissue plasminogen activator and dehydroepiandrosterone sulphate predict cardiovascular death in a 10-year follow up of survivors of acute myocardial infarction. Heart80:334–337, 1998.
24.
ShealyCN. A review of dehydroepiandrosterone (DHEA). Integ Physiol Behav Sci30:308–313, 1995.
25.
MeikleAW, DaynesRA, AraneoBA. Adrenal androgen secretion and biologic effects. Endocrin Metab Clin N Am20:381–400, 1991.
26.
YoungDG, SkibinskiG, SkibinskaA, MasonJI, JamesK.Preliminary studies on the effect of dehydroepiandrosterone (DHEA) on both constitutive and phytohaemagglutinin (PHA)-inducible IL-6 and IL-2 mRNA expression and cytokine production in human spleen mononuclear cell suspensions in vitro. Clin Exp Immunol123:28–35, 2001.
27.
MeikleAW, DorchuckRW, AraneoBA, StringhamJD, EvansTG, SpruanceSL, DaynesRA. The presence of a dehydroepiandrosterone-specific receptor binding complex in murine T cells. J Steroid Biochem Mol Biol42:293–304, 1992.
28.
DuC, SriramS.Induction of interleukin-12/p40 by superantigens in macrophages is mediated by activation of nuclear factor-κB. Cell Immunol199:50–57, 2000.
29.
DuC, SriramS.Mechanism of inhibition of LPS-induced IL-12p40 production by IL-10 and TGF-β in ANA-1 cells. J Leukocyte Biol64:92–97, 1998.
30.
LewisGK, KaminR.Separation of T and B cells using plastic surfaces coated with anti-immunoglobulin antibodies (“panning”). In: MishellBB, ShiigiSM, Eds. Selected Methods in Cellular Immunology. San Francisco: W.H. Freeman and Co., pp227–234, 1980.
31.
BrightJJ, DuC, CoonM, SriramS, KlausSJ. Prevention of experimental allergic encephalomyelitis via inhibition of IL-12 signaling and IL-12-mediated Th1 differentiation: an effect of the novel antiinflammatory drug lisofylline. J Immunol161:7015–7022, 1998.
32.
CrabtreeGR. Contingent genetic regulatory events in T lymphocyte activation. Science243:355–361, 1989.
33.
RobeyE, AllisonJP. T cell activation: integration of signals from the antigen receptor and costimulatory molecules. Immunol Today17:306–310, 1995.
34.
RuddCE. Upstream-downstream: CD28 cosignalling pathways and T cell function. Immunity4:527–534, 1996.
35.
LiH, A L, MalchiodiEL, MariuzzaRA. The structural basis of T cell activation by superantigens. Annu Rev Immunol17:435–466, 1999.
36.
KomadaH, NakabayashiH, MaraM, IzutsuK.Early calcium signaling and calcium requirements for the IL-2 receptor expression and IL-2 production in stimulated lymphocytes. Cell Immunol173:215–220, 1996.
37.
MosmannTR, SadS.The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today17:138–146, 1996.
38.
ConstantS, PfeifferC, WoodardA, PasqualiniT, BottomlyK.Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+ T cells. J Exp Med182:1579–1584, 1995.
39.
TrinchieriG.Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol13:251–276, 1995.
RegelsonW, LoriaR, KalimiM.Hormonal intervention: “buffer hormones” or “state dependency.” Ann NY Acad Sci521:260–273, 1988.
42.
BlauerKL, PothM, RogersWM, BerntonEW. Dehydroepiandrosterone antagonizes the suppressive effects of dexamethasone on lymphocyte proliferation. Endocrinology129:3174–3179, 1991.
43.
SvecF, PorterJR. The actions of exogenous dehydroepiandrosterone in experimental animals and humans. Proc Soc Exp Biol Med218:174–191, 1998.
44.
DworkinCR, GormanSD, PashkoLL, CristofaloVJ, SchwartzAG. Inhibition of growth of HaLa and WI-38 cells by dehydroepiandrosterone and its reversal by ribo- and deoxyribonucleosides. Life Sci38:1451–1457, 1986.
45.
SchulzS, KlannRC, SchonfeldS, NyceJW. Mechanisms of cell growth inhibition and cell cycle arrest in human colonic adenocarcinoma cells by dehydroepiandrosterone: role of isoprenoid biosynthesis. Cancer Res52:1372–1376, 1992.
46.
Lea-CurrieYR, WenP, McIntoshMK. Dehydroepiandrosterone reduces proliferation and differentiation of 3T3-L1 preadipocytes. Biochem Biophy Res Commun248:497–504, 1998.
47.
KawaiS, YahataN, NishidaS, NagaiK, MizushimaY.Dehydroepiandrosterone inhibits B16 mouse melanoma cell growth by induction of differentiation. Anticancer Res15:427–431, 1995.
48.
LoriaRM, PadgettDA, HuynhPN. Regulation of the immune response by dehydroepiandrosterone and its metabolites. J Endocrinol150(Suppl):S209–S220, 1996.
49.
DaynesRA, DudleyDJ, AraneoBA. Regulation of murine lymphokines production in vivo: II. Dehydroepiandrosterone is a natural enhancer of interleukin 2 synthesis by helper T cells. Eur J Immunol20:793–780, 1990.
50.
MoynihanJA, CallahanTA, KelleySP, CampbellLM. Adrenal hormone modulation of type 1 and type 2 cytokine production by spleen cells: dexamethasone and dehydroepiandrosterone suppress interleukin-2, interleukin-4, and interferon-γ production in vitro. Cell Immunol184:58–64, 1998.
51.
CatalinaF, KumarV, MilewichL, BennettM.Food restriction-like effects of dehydroepiandrosterone: decreased lymphocyte numbers and functions with increased apoptosis. Proc Soc Exp Biol Med221:326–335, 1999.
52.
TuostoL, CundariE, MontaniMG, PicolellaE.Analysis of susceptibility of mature human T lymphocytes to dexamethasone-induced apoptosis. Eur J Immunol24:1061–1065, 1994.
53.
ZacharchukCM, MercepM, ChakrabortiPK, SimonsSS, AshwellJD. Programmed T lymphocyte death: cell activation- and steroid-induced pathways are mutually antagonistic. J Immunol145:4037–4045, 1990.
RookGAW, Hernandez-PandoR, LightmanSL. Hormones, peripherally activated prohormones and regulation of the Th1/Th2 balance. Immunol Today15:301–303, 1994.
56.
NelmsK, KeeganAD, ZamoranoJ, RyanJJ, PaulWE. The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol17:701–738, 1999.
57.
GatelyMK, RenzettiLM, MagramJ, SternAS, AdoriniL, GublerU, PreskyDH. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu Rev Immunol16:495–521, 1998.
58.
WuMF, ChangHL, TsengJ.Dehydroepiandrosterone induces the transforming growth factor-β production by murine macrophages. Int J Tissue React19:141–148, 1997.
59.
SchmittE, HoehnP, GoedertS, PalmN, RudeE, GermannT.T helper type 1 development of naive CD4+ T cells requires the coordinate action of interleukin-12 and interferon-γ and is inhibited by transforming growth factor-β. Eur J Immunol24:793–798, 1994.
60.
PadgettDA, LoraRM. Endocrine regulation of murine macrophage function: effect of dehydroepiandrosterone androstenediol, and androstenetroil. J Neuroimmunol84:61–68, 1998.
61.
ShibuyaK, RobinsonD, ZoninF, HartleySB, MacatoniaSE, SomozaC, HunterCA, MurphyKM, O'GarraA.IL-1α and TNF-α are required for IL-12-induced development of Th1 cells producing high levels of IFN-γ in BALB/c but not C57BL/6 mice. J Immunol160:1708–1716, 1998.
62.
NelmsK, HuangH, RyanJ, KeeganA, PaulWE. Interleukin-4 receptor signalling mechanisms and their biological significance. In: BackN, CohnIR, KritchevskyD, LajthaA, PaolettiR, Eds. Advances in Experimental Medicine and Biology. New York: Plenum Press, Vol 452:pp37–43, 1998.
63.
BaconCM, McVicarDW, OrtaldoJR, ReesRC, O'SheaJJ. Interleukin-12 induces tyrosine phosphorylation of Jak-2 and Tyk-2: differential use of Janus tyrosine kinases by interleukin-12. J Exp Med181:399–104, 1995.
64.
JacobsonNG, SzaboSJ, Weber-NordtRM, ZhongZ, SchreiberRD, DarnellJE, MurphyKM. Interleukin-12 signaling in Th1 cells involves tyrosine phosphorylation of Stat3 and Stat4. J Exp Med181:1755, 1995.
65.
ZhangS, KaplanMH. The p38 mitogen-activated protein kinase is required for IL-12-induced IFN-γ expression. J Immunol165:1374–1380, 2000.
66.
EvensRM. The steroid and thyroid hormone receptor superfamily. Science240:889–895, 1988.
67.
OkabeT, HajiM, TakayanagiR, AdachiM, ImasakiK, KurimotoF, WatanabeT, NawataH.Up-regulation of high-affinity dehydroepiandrosterone binding activity by dehydroepiandrosterone in activated human T lymphocytes. J Clin Endocrinol Metab80:2993–2996, 1995.
68.
FurutamaD, FukuiR, AmakawaM, OhsawaN.Inhibition of migration and proliferation of vascular smooth muscle cells by dehydroepiandrosterone sulfate. Biochim Biophy Acta1406:107–114, 1998.
